Curis | CRIS - Fremdkapital





Fremdkapital Veränderung Datum
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Amgen USD 51.89B 1.88B 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Bayer EUR 31.83B 877M 2025-12
Bristol-Myers Squibb USD 42.15B 698M 2026-03
CSL USD 10.42B 273M 2025-12
Curis USD 29.43M 10.69M 2024-06
Eli Lilly USD 39.37B 1.5B 2026-03
Gilead Sciences USD 22.13B 6M 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
Incyte USD 29.41M 785K 2026-03
Merck USD 46.67B 77M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Takeda JPY 4.27T 81.29B 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Verastem USD 81.33M 31.01M 2025-12
Xoma USD 94.38M 7.82M 2025-09